Drug Type Synthetic peptide |
Synonyms TIP-PEPTIDE, AP-301 |
Target |
Mechanism ENaC agonists(Epithelial sodium channel agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC82H119N23O27S2 |
InChIKeyLKVFMOMQYXIFRK-KSVAIKAXSA-N |
CAS Registry259206-53-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Edema | Phase 2 | AT | 23 May 2018 | |
Pulmonary Edema | Phase 2 | DE | 23 May 2018 | |
Respiratory Distress Syndrome | Phase 2 | AT | 23 May 2018 | |
Respiratory Distress Syndrome | Phase 2 | DE | 23 May 2018 | |
Reperfusion Injury | Phase 2 | AT | 24 May 2013 | |
Acute Lung Injury | Phase 2 | AT | 01 Jul 2012 | |
Pseudohypoaldosteronism | Preclinical | AT | - |
Not Applicable | - | przyyywzmw(nrrckmtstb) = nedzdfcbyf luleobgwuk (znkhidvkpn ) View more | - | 01 Sep 2011 | |||
Ro32-4032 | xotqwxvoig(ihnuihorrc) = kwiapqhexh ubgfdfelds (ubzuxlxyvm ) |